Language

News topic

ATC group G04BD07

Current shortage notices for the ATC group G04BD07, structured by product, country and reporting period.

8 notices

← All shortages

What the G04BD07 notices indicate for the supply chain

The 8 consolidated notices from Belgium, Austria, Denmark are market and supply signals. They do not confirm current Inter-Pharma stock or a general ability to supply. Operational assessment requires separate verification of product status, batch, expiry, temperature requirements, recipient authorisation and the permitted distribution route.

GDP-capable pharmaceutical storage in Cheb

Inter-Pharma supports manufacturers, wholesalers and logistics partners with GDP-capable pharmaceutical storage in Czechia. Its own Cheb site enables project-specific buffer and safety stocks, batch and expiry control, FEFO, stock-status management, picking and dispatch preparation for Germany and Europe.

Belgium

Urolina 4 mg hard caps. prol.-rel. 84

Active ingredient: Tolterodine

View notice details →
Belgium

Tolterodine Retard Teva 4 mg hard caps. prol.-rel. 84

Active ingredient: Tolterodine

View notice details →
Belgium

Tolterodine Retard Teva 4 mg hard caps. prol.-rel. 28

Active ingredient: Tolterodine

View notice details →
Austria

Detrusitol 1 mg - Filmtabletten

Active ingredient: TOLTERODIN TARTRAT

View notice details →
Austria

Detrusitol 2 mg - Filmtabletten

Active ingredient: TOLTERODIN TARTRAT

View notice details →
Denmark

Detrusitol Retard 2 mg depotkapsler, hårde

Active ingredient: Tolterodin (tolterodintartrat)

View notice details →
Denmark

Tolterodin "Stada" 4 mg depotkapsler, hårde

Active ingredient: Tolterodin (Tolterodintartrat)

View notice details →
Denmark

Tolterodin "Stada" 2 mg depotkapsler, hårde

Active ingredient: Tolterodin (Tolterodintartrat)

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.